Alcresta Therapeutics is a brand that develops enzyme-based products to improve nutritional care for patients with rare diseases. They are committed to delivering innovative medical devices that provide enzymatic solutions for enteral nutrition. Based in Massachusetts, Alcresta Therapeutics has achieved significant commercial milestones and has developed an extensive intellectual property portfolio.

Their products and technology platform have been optimized with exciting scientific data. Alcresta Therapeutics is driven by their mission to meet critical unmet needs and make a difference in the lives of patients living with critical conditions and rare diseases. The brand is guided by their core values, which include innovation, leadership, and passion.

Their leadership team includes individuals with extensive experience in executive management, corporate development, legal and compliance, and commercial operations. Alcresta Therapeutics continues to pave a new therapeutic pathway and improve nutritional care for enterally fed patients